UnitedHealth Group

After three years, Amgen has to pay Regeneron Pharmaceuticals more than $400m in damages after a federal court jury found the biotech liable for violating antitrust and tort laws by allegedly using ag

When the Federal Trade Commission (FTC) officially accused the three largest PBMs of artificially inflating insulin prices, it marked the latest move in what has become a protracted effort by federa

UnitedHealth Group saw “rapid acceleration in the prescribing of certain high-cost specialty medications” in its Medicare Advantage prescription drug plans in the third quarter. Prescribing increased

Effective obesity drugs were a long time coming, but they have arrived amid a flurry of other treatment innovations, from new migraine therapies to gene therapies for sickle cell disease. This, combin